Alemtuzumab Biosimilar - Research Grade,ichor.bio,ICH4002
Detects human CD52. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Alemtuzumab.
Host
Humanized
Reactivity
Human
Platform ID
BAB195371677
ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NameAlemtuzumab Biosimilar - Research Grade
Cat. No.ICH4002
Accession NumberP31358
HostHumanized
IsotypeHuman IgG1 Kappa
ReactivityHuman
Concentration1.0 - 5.0 mg/ml
TargetCD52
Purity>95% by SDS-PAGE and HPLC
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3001-100ml
ICH3002-100ml
ICH3003-100ml
StorageStable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory StatusFor research use only
Scientific Background
Alemtuzumab biosimilar is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H) directed against the 21-28 kD cell surface glycoprotein, CD52, is an IgG1 kappa antibody with human variable framework and constant regions, and complementarity
Synonyms
Campath-1 antigen, Cambridge pathology 1 antigen, HE5
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.